Allianz Asset Management GmbH - INTERCEPT PHARMACEUTICALS IN ownership

INTERCEPT PHARMACEUTICALS IN's ticker is and the CUSIP is 45845PAA6. A total of 50 filers reported holding INTERCEPT PHARMACEUTICALS IN in Q2 2019. The put-call ratio across all filers is - and the average weighting 0.2%.

Quarter-by-quarter ownership
Allianz Asset Management GmbH ownership history of INTERCEPT PHARMACEUTICALS IN
ValueSharesWeighting
Q2 2020$18,400,000
-37.6%
24,475,000
-32.7%
0.02%
-47.5%
Q1 2020$29,468,000
-63.3%
36,360,000
-54.3%
0.04%
-45.2%
Q4 2019$80,207,000
+14.8%
79,610,000
-0.7%
0.07%
+5.8%
Q3 2019$69,869,000
-1.9%
80,210,0000.0%0.07%
+4.5%
Q2 2019$71,198,000
-26.0%
80,210,000
-17.3%
0.07%
-30.5%
Q1 2019$96,216,000
+17.3%
96,985,000
+5.6%
0.10%
+5.6%
Q4 2018$82,043,000
-13.6%
91,840,000
-3.1%
0.09%
+4.7%
Q3 2018$94,974,000
+148.1%
94,760,000
+118.4%
0.09%
+132.4%
Q2 2018$38,287,000
+11.0%
43,385,0000.0%0.04%
+12.1%
Q1 2018$34,491,000
-5.4%
43,385,000
-3.3%
0.03%
+13.8%
Q4 2017$36,469,000
+0.9%
44,885,000
-3.2%
0.03%
-6.5%
Q3 2017$36,157,000
+823.3%
46,385,000
+1059.6%
0.03%
+675.0%
Q2 2017$3,916,000
+5.0%
4,000,0000.0%0.00%0.0%
Q1 2017$3,728,000
+3.4%
4,000,0000.0%0.00%
+33.3%
Q4 2016$3,606,000
-87.0%
4,000,000
-83.8%
0.00%
-88.9%
Q3 2016$27,754,00024,765,0000.03%
Other shareholders
INTERCEPT PHARMACEUTICALS IN shareholders Q2 2019
NameSharesValueWeighting ↓
Worth Venture Partners, LLC 5,324,000$4,995,0003.78%
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) 57,791,000$53,020,0002.12%
DLD Asset Management, LP 32,500,000$30,048,0002.06%
Castle Creek Arbitrage, LLC 4,504,000$4,161,0001.43%
TENOR CAPITAL MANAGEMENT Co., L.P. 10,000,000$9,372,0000.62%
Graham Capital Management, L.P. 14,636,000$13,509,0000.60%
OAKTREE CAPITAL MANAGEMENT LP 64,452,000$59,704,0000.54%
Context Capital Management, LLC 1,000,000$926,0000.52%
ADVENT CAPITAL MANAGEMENT /DE/ 23,118,000$21,341,0000.52%
WOLVERINE ASSET MANAGEMENT LLC 18,583,000$17,322,0000.21%
View complete list of INTERCEPT PHARMACEUTICALS IN shareholders